James Leverenz, MD, emphasizes the value of early diagnosis of Alzheimer’s disease alongside the current clinical management options for patients with the early stages of Alzheimer’s disease after a diagnosis.
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.